LP230269-5
Leucine-rich glioma-inactivated protein 1
Active
Description
Leucine-rich glioma-inactivated protein 1 (LGI1) is part of a group of antigens that have target antibodies that bind to neuronal cell surface or synaptic proteins but are not associated with a malignancy. The ensuing encephalitis has been designated neuronal surface antibody syndrome or autoimmune synaptic encephalitis. LGI1 antibodies have been associated with encephalitis that responds well to treatment and has a good expected outcome. PMID: 25520958 Source: Regenstrief LOINC
Basic Part Properties
- Part Display Name
- Leucine-rich glioma-inactivated protein 1
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2016-09-29
- Construct for LOINC Short Name
- LGI1
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP230269-5
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 富亮氨酸胶质瘤失活蛋白 1 Synonyms: 富亮氨酸胶质瘤失活1蛋白; |
| es-ES | Spanish (Spain) | Proteína 1 inactivada del glioma rica en leucina |
| it-IT | Italian (Italy) | Proteina 1 glioma-inattivata ricca di leucina |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright